Gsk Share Discussion Threads

[montyhedge] 12/4/2024 15:50

Pound at three month low, great for FTS 100 dollars. Most companies are.Be nice to see pound below 1.20 to dollar.

[tradermichael] 11/4/2024 14:03

IN @ 1625.75 ..... ;0)

[tradermichael] 11/4/2024 12:35

Dividend payment reached my AJ Bell accounts this morning ....

[tradermichael] 10/4/2024 14:32

The Government said that it had removed this recommendation hours before the guidelines were published.......... however, you are correct - a seriously misplaced drive - healthcare should never be compromised on environmental considerations and should never have entered the discussion.

[lippy4] 10/4/2024 13:18

what are the names of these people who say they should make fewer drugs,its always the same with these government statements of some spokesman who we are not told their name, its a hidden agenda it seems..

name them i say???

[supermarky] 10/4/2024 10:31

gsk on the naughty list at the moment

[tradermichael] 09/4/2024 14:35

See how Delaware goes first ........

[patientcapital] 09/4/2024 14:00

Perhaps GSK should re home to the US along with a multitude of others.

[alphorn] 09/4/2024 13:00

Yes, totally nuts!

Pharmaceuticals companies were told to make fewer drugs for the sake of the environment, in new draft guidelines for businesses in the Government’s latest net zero drive. The suggestion was among a vast array of proposals which Britain’s biggest businesses have been told to consider as they are ordered to publish lengthy reports every year to show how they plan to meet their net zero targets.

The Government said that it had removed this recommendation hours before the guidelines were published..........

[supermarky] 09/4/2024 12:45

https://www.telegraph.co.uk/business/2024/04/09/uk-pharma-companies-told-to-make-fewer-drugs-in-draft-treas/I dispair at this insane country.We have obviously been infiltrated by agents from enemy states.

[tradermichael] 09/4/2024 08:12

Barclays 08/04/2024 Equal-weight Target 1,725.00p Reiteration

[upomega] 06/4/2024 08:16

Alternativatly a new tax year. Guesss what. it is Monday... Maybe even the good old us will help the share price out.

[alibizzle] 05/4/2024 10:45

Need some good.news from.delaware to turn this around

[tradermichael] 05/4/2024 10:42

Wrong date, wrong thread ....

[blackhorse23] 05/4/2024 09:17

https://www.londonstockexchange.com/news-article/APH/full-year-trading-update/16307097

[spoole5] 05/4/2024 08:01

Back to normal for this then

[patientcapital] 04/4/2024 16:44

I've felt the market was pricing that in already to an extent.

[alibizzle] 04/4/2024 13:50

GSK probably go down same route as sanofi .

[tradermichael] 04/4/2024 13:36

SANOFI has reached an agreement in principle to settle 4,000 US lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday (Apr 3). Sanofi did not disclose the financial terms of the deal.

[motorhead75] 03/4/2024 19:31

My musings..
I think the price isn’t going to move a great deal and will bounce around between £16.50-17.20 range up until the Zantac result in June/July.
If we get a positive result, I can see £18.50+ quite quickly- remember the 14% jump after the federal court case result?!
If it’s not in our favour, maybe a £1.50 drop, but regained steadily and will continue to climb.. I do think potential payouts are factored in to the current share price.
It’ll be nice to see this share being given a fair valuation finally- the whole Zantac litigation reaction has baffled me.
I work for GSK and have held shares for thirty years.. hopefully this time next year Rodney, we’ll all be millionaires!

[tradermichael] 03/4/2024 09:35

If the price remains soft I'll be buying in again with the help of GSK's next dividend payment of 16p per share on Apr 11, 2024.

[geckotheglorious] 03/4/2024 08:21

GSK picking up momentum, says HL’s Clayton
GSK (GSK) is ‘fighting back into contention’ with a bumper crop of new product launches in the pipeline, says Hargreaves Lansdown manager Steve Clayton.

Clayton holds the Citywire Elite Companies AAA-rated pharmaceutical giant in his HL Select UK Income Shares fund, where it makes up 3% of the £138m portfolio.

The group has been focused on restructuring, with a spin out of its consumer division Haleon (HLN), and developing new medicines such as shingles vaccine Shingrix, which Clayton said is ‘already a multi-billion dollars a year product’.

The arrival of US activist investors Elliott Management a few years ago highlighted ‘the weak returns GSK had achieved, despite some real clinical strengths within the business’.

‘The company is now more optimistic about its research pipeline delivering more meaningful new drugs than for many years,’ Clayton said.

‘GSK’s business has more clarity about it these days and its current pipeline of 71 assets is predicted by GSK to contain at least 12 major new products to be launched from 2025 onwards.’

The shares dropped 2.5% to £16.65 on Tuesday, but have added almost 16% over the last 12 months.

[tradermichael] 02/4/2024 13:21

It doesn't really matter .... the underlying trend is up - rarely does a share of this magnitude go up in a continuous straight line .... ;o)

[garycook] 02/4/2024 10:08

TM I think you are wrong, GSK were marked down at 8am start of trading by over 2%. With a UT trade of 1653p.There are currently more Buyers than Sellers atm !

[tradermichael] 02/4/2024 09:18

Profit taking ahead of Financial Year end this week?